Investigating Glucose Metabolism of LEAP2 With Total-body PET/CT

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 21, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions

Obesity

Interventions

BIOLOGICAL

Exogenous LEAP2 hormone

This intervention has never been examined in this type of study before.

Trial Locations (1)

Center for Clinical Metabolic Research, Gentofte Hospital, Hellerup

All Listed Sponsors

lead

University Hospital, Gentofte, Copenhagen

OTHER